Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Original Research

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis

       
Total article views   HTML views PDF downloads Totals
2,637 Dovepress* 2,422+ 77 2,499
PubMed Central* 215 112 327
Totals 2,637 189 2,826
*Since 6 September 2023

View citations on PubMed Central and Google Scholar